slotkoers
Korea S.E.
00:00:00 20-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.760
KRW
|
+1,35%
|
|
+0,27%
|
-19,49%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
289.037
|
371.356
|
343.320
|
120.105
|
90.356
|
Bedrijfswaarde
1 |
271.032
|
313.780
|
292.285
|
87.814
|
47.869
|
K/w-verhouding
|
-13
x
|
-16,6
x
|
-15,4
x
|
-5,02
x
|
-3,91
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
-
|
70.267.270
x
|
14.182.506
x
|
10.004.182
x
|
Bedrijfswaarde/omzet
|
-
|
-
|
59.821.903
x
|
10.369.450
x
|
5.300.023
x
|
Bedrijfswaarde/EBITDA
|
-11,9
x
|
-15,3
x
|
-12,4
x
|
-3,28
x
|
-2,14
x
|
Bedrijfswaarde/FCF
|
-
|
-25.757.721
x
|
-18.044.033
x
|
-5.698.936
x
|
-3.481.032
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
17,6
x
|
6,72
x
|
6,87
x
|
4,24
x
|
2,87
x
|
Aantal aandelen (in duizenden)
|
12.320
|
14.178
|
14.730
|
14.730
|
19.348
|
Referentieprijs
2 |
23.462
|
26.192
|
23.308
|
8.154
|
4.670
|
Datum van publicatie
|
17/03/21
|
17/03/21
|
17/03/22
|
17/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
|
-
|
-
|
4.886
|
8.469
|
9.032
|
EBITDA
1 |
-22.725
|
-20.484
|
-23.578
|
-26.758
|
-22.394
|
Bedrijfsresultaat (EBIT)
1 |
-23.170
|
-21.025
|
-24.243
|
-27.475
|
-23.213
|
Operationele Marge
|
-
|
-
|
-496,18%
|
-324,43%
|
-257,02%
|
Resultaat voor belastingen (EBT)
1 |
-22.698
|
-20.773
|
-23.884
|
-27.118
|
-22.249
|
Nettowinst (verlies)
1 |
-22.698
|
-20.498
|
-22.848
|
-25.457
|
-21.117
|
Nettomarge
|
-
|
-
|
-467,63%
|
-300,61%
|
-233,8%
|
WPA
2 |
-1.800
|
-1.575
|
-1.518
|
-1.623
|
-1.193
|
Free Cash Flow
|
-
|
-12.182
|
-16.198
|
-15.409
|
-13.751
|
FCF-marge
|
-
|
-
|
-331,53%
|
-181,95%
|
-152,25%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
17/03/21
|
17/03/21
|
17/03/22
|
17/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
18.004
|
57.576
|
51.035
|
32.291
|
42.487
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-12.182
|
-16.198
|
-15.409
|
-13.751
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-55,9%
|
-42,7%
|
-60,8%
|
-52,3%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-32,3%
|
-25,6%
|
-35,8%
|
-31,9%
|
Totale activa
1 |
-
|
63.429
|
89.294
|
71.185
|
66.164
|
Nettoactief per aandeel
2 |
1.330
|
3.895
|
3.395
|
1.922
|
1.627
|
Cashflow per aandeel
2 |
295,0
|
327,0
|
1.254
|
1.307
|
1.241
|
Capex
1 |
12,5
|
10,7
|
147
|
12,8
|
-
|
Capex/omzet
|
-
|
-
|
3%
|
0,15%
|
-
|
Datum van publicatie
|
17/03/21
|
17/03/21
|
17/03/22
|
17/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -19,49% | 88,62 mln. | | +30,30% | 78,37 mld. | | +3,54% | 25,35 mld. | | +8,31% | 8,85 mld. | | +13,45% | 8,85 mld. | | -30,05% | 7,21 mld. | | +17,70% | 5,33 mld. | | +1,92% | 4,15 mld. | | -7,07% | 3,47 mld. | | +9,54% | 3,32 mld. |
geneesmiddelen groothandels
|